Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A joint meeting was held in July 2009 in Houston, Texas, of members of the Spondyloarthritis Research and Therapy Network (SPARTAN), founded in 2003 to promote research, education, and treatment of ankylosing spondylitis (AS) and related forms of spondyloarthritis (SpA), and members of International Genetics of AS (IGAS), founded in 2003 to encourage and coordinate studies internationally in the genetics of AS. The general topic was the genetic basis of SpA, with presentations on the future of human genetic studies; microbes, SpA, and innate immunity; susceptibility of AS to the major histocompatibility complex (MHC) and non-MHC; and individual discussions of the genetics of psoriasis and psoriatic arthritis, uveitis, inflammatory bowel disease, and enteropathic arthritis. Summaries of those discussions are presented.

Original publication

DOI

10.3899/jrheum.100892

Type

Journal article

Journal

The Journal of rheumatology

Publication Date

12/2010

Volume

37

Pages

2626 - 2631

Addresses

University of Bristol, Bristol, UK.

Keywords

Humans, Spondylarthritis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Uveitis, Psoriasis, Genetic Predisposition to Disease, Major Histocompatibility Complex, Texas, Congresses as Topic, Immunity, Innate, Genome-Wide Association Study